Clinical relevance of anti-exenatide antibodies: safety, efficacy and cross-reactivity with long-term treatment

M.S. Fineman, K.F. Mace, M. Diamant, T. Darsow, B.B. Cirincione, T.K.B. Porter, L.A. Kinninger, M.E. Trautmann

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)546-554
JournalDiabetes, Obesity and Metabolism
Volume14
Issue number6
DOIs
Publication statusPublished - 2012

Cite this

Fineman, M. S., Mace, K. F., Diamant, M., Darsow, T., Cirincione, B. B., Porter, T. K. B., ... Trautmann, M. E. (2012). Clinical relevance of anti-exenatide antibodies: safety, efficacy and cross-reactivity with long-term treatment. Diabetes, Obesity and Metabolism, 14(6), 546-554. https://doi.org/10.1111/j.1463-1326.2012.01561.x